Skip to main content
Clinical Trials/CTRI/2024/07/070244
CTRI/2024/07/070244Not yet recruitingPhase 3 4

Clinical Verification of Rubrical Representation of Attention Deficit Hyperactivity Disorder related symptoms of Tarentula hispanica in Synthesis Repertory

Sarada Krishna Homoeopathic Medical College1 site in 1 country30 target enrollmentStarted: July 15, 2024Last updated:

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
To find out reliability of rubrics related to ADHD representing Tarentula hispanica in synthesis repertory

Study Overview

Brief Summary

Attention Deficit Hyperactivity Disorder is a prevalent neurodevelopmental disorder nowadays. Early diagnosis and treatment of Attention Deficit Hyperactivity Disorder in children  is necessary to reduce risk of complication in later years. The need of this study is to prove potential role of Tarentula hispanica in the management of symptoms of attention deficit hyperactivity disorder in  synthesis repertory. This study focuses on verification of rubrics related to Attention Deficit Hyperactivity Disorder of Tarentula hispanica in synthesis repertory. The rubrics related to Attention Deficit Hyperactivity Disorder with representation of Tarentula hispanica is available in synthesis repertory . The reliability of rubrics related to Attention Deficit Hyperactivity Disorder with representation of  Tarentula hispanica is yet to be verified. Daily one Dose of Tarentula hispanica will be administered orally with a regular follow-up in every 2 weeks. The study will be conducted for the period of 6 months. The case will be assessed using Vanderbuilt Diagnostic Parent Rating Scale. The reliability is verified through observing the clinical course of Attention Deficit Hyperactivity Disorder during treatment with Tarentula hispanica and also changes in symptom with respect to time. The study will be statistically analyzed by using paired t test.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
4.00 Year(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients having symptomatology of Tarentula hispanica All types of diagnostic cases of Attention Deficit Hyperactivity Disorder.

Exclusion Criteria

  • Age above 19 years Patients having other behavioral diseases Patients with severe systemic illness Children under long term medication.

Outcomes

Primary Outcomes

To find out reliability of rubrics related to ADHD representing Tarentula hispanica in synthesis repertory

Time Frame: 6 months

Secondary Outcomes

  • Changes in symptoms of Attention Deficit Hyperactivity Disorder with respect to time in every 2 weeks(Changes in the symptoms of Attention Deficit hyperactivity disorder of Tarentula hispanica in synthesis repertory every 3 months)

Investigators

Sponsor
Sarada Krishna Homoeopathic Medical College
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Surya Gayathri V

Sarada Krishna Homoeopathic Medical College

Study Sites (1)

Loading locations...

Similar Trials